Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.4900
-0.0100 (-2.00%)
Aug 21, 2026, 4:10 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 106.58 million as of August 21, 2026. Its market cap has decreased by -10.96% in one year.
Market Cap
106.58M
Enterprise Value
57.48M
Revenue
6.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
ChartMarket Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 106.58M, an increase of 106.91%. That is a compound annual growth rate of 2.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 106.58M | 22.50% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nyrada | 182.70M |
| Actinogen Medical | 168.27M |
| Island Pharmaceuticals | 136.12M |
| Recce Pharmaceuticals | 112.30M |
| Paradigm Biopharmaceuticals | 103.95M |
| LTR Pharma | 89.98M |
| Avecho Biotechnology | 81.14M |
| Prescient Therapeutics | 80.97M |